Trimeris Inc. - redOrbit

News - Trimeris Inc.

Arigene Co., Ltd. Announces Termination of Tender Offer To Purchase and Return of Validly Tendered Shares of Common Stock of Trimeris, Inc.

2009-12-29 07:08:00

SEOUL, South Korea, Dec. 29 /PRNewswire/ -- Arigene Co., Ltd., a Korean corporation traded on the Korean Securities Dealers Association Quotation System ("Arigene") (KOSDAQ: 067850), today announced the termination of the tender offer for the outstanding common stock of Trimeris, Inc.

Arigene Co., Ltd. Enters Into Amendment To Merger Agreement With Trimeris, Inc.

2009-11-17 08:32:00

SEOUL, South Korea, Nov.

Results With New Integrase Inhibitor Plus FUZEON and Boosted Protease Inhibitor Show Remarkable Undetectable Rate of 98 Percent in Treatment-Experienced HIV Patients

2007-03-01 15:00:20

Virtually all patients (98 percent) who received t

CORRECTING and REPLACING New Data Show Unprecedented Undetectable Rates of Over 90 Percent in HIV Patients Receiving FUZEON(R) and Investigational Integrase Inhibitor MK-0518

2006-10-05 18:00:50

Please replace the release with the following corrected version due to multiple revisions.

New Data Show Unprecedented Undetectable Rates of Over 90 Percent in HIV Patients Receiving FUZEON(R) and Investigational Integrase Inhibitor MK-0518

2006-10-05 03:00:21

New data presented at the 46th annual Interscienc